Barely Significant
← all excerpts

A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome.

Open Neurol J · 2012 · PMC3474942 · PMID 23091568

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

at the margin of significancep= 0.053so close (0.05 < p ≤ 0.1)
On the specific drug vs placebo comparison at week 12, the preferential improvement for drug in overall cognition fell at the margin of significance (p= 0.053); because this fell at the margin of significance and because the sample size was small, this result must be viewed with caution, and requires replication for confirmation of a treatment effect, as there is a slightly increased risk that this result occurred by chance.

also in 31 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.